| Literature DB >> 35418932 |
Joshua P Kulasingham1, Christian Brodbeck2, Sheena Khan3, Elisabeth B Marsh3, Jonathan Z Simon1,4,5.
Abstract
Stroke patients with hemiparesis display decreased beta band (13-25 Hz) rolandic activity, correlating to impaired motor function. However, clinically, patients without significant weakness, with small lesions far from sensorimotor cortex, exhibit bilateral decreased motor dexterity and slowed reaction times. We investigate whether these minor stroke patients also display abnormal beta band activity. Magnetoencephalographic (MEG) data were collected from nine minor stroke patients (NIHSS < 4) without significant hemiparesis, at ~1 and ~6 months postinfarct, and eight age-similar controls. Rolandic relative beta power during matching tasks and resting state, and Beta Event Related (De)Synchronization (ERD/ERS) during button press responses were analyzed. Regardless of lesion location, patients had significantly reduced relative beta power and ERS compared to controls. Abnormalities persisted over visits, and were present in both ipsi- and contra-lesional hemispheres, consistent with bilateral impairments in motor dexterity and speed. Minor stroke patients without severe weakness display reduced rolandic beta band activity in both hemispheres, which may be linked to bilaterally impaired dexterity and processing speed, implicating global connectivity dysfunction affecting sensorimotor cortex independent of lesion location. Findings not only illustrate global network disruption after minor stroke, but suggest rolandic beta band activity may be a potential biomarker and treatment target, even for minor stroke patients with small lesions far from sensorimotor areas.Entities:
Keywords: Event Related Synchronization; beta band power; magnetoencephalography; minor stroke; rolandic beta
Year: 2022 PMID: 35418932 PMCID: PMC8996122 DOI: 10.3389/fneur.2022.819603
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Clinical and behavioral measures.
|
|
|
|
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| 1 | 4 | 0 | 1 | 24 | −1.5 | −3.6 | 0 | 1 | 26 | −2.8 | −0.6 | 0 | 0 | 2 | −1.3 | 3 |
| 2 | 0 | 0 | 1 | 26 | −3.3 | −3.5 | 0 | 0 | 27 | −4.1 | −5.2 | 0 | −1 | 1 | −0.8 | −1.7 |
| 3 | 3 | 3 | 1 | 21 | −5 | −14.9 | 0 | 1 | 20 | −8.4 | −14.1 | −3 | 0 | −1 | −3.4 | 0.8 |
| 4 | 2 | 2 | 1 | 24 | −15.7 | −14.1 | 0 | 0 | 29 | −0.4 | −1.1 | −2 | −1 | 5 | 15.3 | 13 |
| 5 | 1 | 0 | 0 | 28 | −7.8 | −9.3 | 1 | 1 | 30 | −3.2 | −12.1 | 1 | 1 | 2 | 4.6 | −2.8 |
| 6 | 3 | 0 | 1 | 28 | −2.1 | −6.1 | 0 | 0 | 27 | −0.8 | −4.5 | 0 | −1 | −1 | 1.3 | 1.6 |
| 7 | 12 | 0 | 1 | 28 | −0.9 | −1.7 | ||||||||||
| 8 | 4 | 1 | 2 | 22 | −4.5 | −3.2 | ||||||||||
| 9 | 1 | 0 | 1 | 27 | −14.8 | −1.9 | ||||||||||
| Mean | 3.3 | 0.7 | 1 | 25.3 | −6.2 | −6.5 | 0.2 | 0.5 | 26.5 | −3.3 | −6.3 | −0.6 | −0.3 | 1.3 | 2.6 | 2.3 |
| SD | 3.5 | 1.1 | 0.5 | 2.7 | 5.6 | 5.1 | 0.4 | 0.5 | 3.5 | 2.9 | 5.6 | 1.5 | 0.8 | 2.3 | 6.8 | 5.6 |
GPBi, Grooved Peg Board ipsi-lesional hand reaction time (units in s.d. from the population average); GPBc, Grooved Peg Board contra-lesional hand reaction time. Patients show abnormal GPB scores bilaterally that improve but remain impaired for the 2nd visit.
Lesion locations.
|
|
|
| ||
|---|---|---|---|---|
| 1 | L | SC | 10.5 | Basal ganglia, parasagittal parietal cortex, and posterior centrum semiovale |
| 2 | L | SC | 2 | Left fronto-parietal and parieto-occipital junction |
| 3 | R | SC | 1.6 | Basal ganglia, centrum semiovale, corona radiata and borderzone regions |
| 4 | R | S | 0.4 | Corona radiata |
| 5 | R | S | 0.3 | Thalamus |
| 6 | R | S | 6.8 | Basal ganglia and posterior limb of the internal capsule |
| 7 | R | S | 1.3 | Thalamus |
| 8 | L | S | 2 | Basal ganglia |
| 9 | L | C | 0.7 | Subcentral gyrus |
loc., location of lesion; S, subcortical; C, cortical; SC, subcortico-cortical; hemi., lesion hemisphere; size, lesion volume in cc.
Figure 1Beta power in controls and patients. (A) Source localized beta band power for controls and patients averaged across all tasks. The black outline indicates the ROI used for all further analysis. Although patients and controls have similar beta activity in occipital areas, controls have much stronger activity in the rolandic ROI. (B) Power spectral density of patients and controls averaged across all tasks in the central ROI for the 1st visit. There is a clear group difference in the beta range (13–25 Hz). (C) Relative beta power for controls and patients for the 1st visit, separated by ipsi-lesional and contra-lesional hemispheres. Clear differences between controls and patients are seen, but there are no notable differences within patients between ipsi-lesional and contra-lesional hemispheres. (D) Power spectral density for the 2nd visit. Note that only a subset of subjects returned for the 2nd visit. The 1st visit spectrum averaged across only this subset of subjects is shown as an inset for comparison. (E) Relative beta power for controls and patients for the 2nd visit, separated by ipsi-lesional and contra-lesional hemispheres. Patients show reduced power even after ~6 months postinfarct. There are no notable differences within patients for ipsi- and contra-lesional hemispheres.
Figure 2Beta ERD and ERS for controls and patients. (A–D) The spectrograms for controls and patients (normalized w.r.t. baseline activity) are shown. The movement (button press) occurred at time t = 0. The dashed line indicates the beta band (13–25 Hz) that was used for further analysis. (E,F) Beta power modulation per subject, computed as the average power in the beta band. Patients have reduced beta ERD/ERS. (G,H) Beta ERD/ERS (% change from baseline) for controls and patients, separated by ipsi- and contra-lesional hemispheres. Patients have reduced ERD and ERS compared to controls for both visits, but show no differences across hemispheres. The group difference is much larger for the ERS than for the ERD.